Maria Kourilovitch
Maria Kourilovitch has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Claudio Galarza-Maldonado
Unidad de Enfermedades Reumáticas y Autoinmunes (UNERA), Hospital Monte Sinaí, Cuenca, Ecuador
4 shared publications Christian Cordero
1 shared publicationClaudio Galarza-Maldonado
Corporación Médica Monte Sinaí
1 shared publicationClaudio Galarza–Maldonado
Unidad de Enfermedades Reumáticas y Autoinmunes (UNERA), Corporación Médica Monte Sinai, Miguel Cordero 6-111 y av. Solano, Cuenca, Ecuador
1 shared publication- Esteban Ortiz-Prado
One Health Research Group, Universidad de Las Américas, Quito, Ecuador
1 shared publication - Jessica Bravo-Barrera
UNERA (Unit of Rheumatic and Autoimmune Diseases), Hospital Monte Sinaí, Miguel Cordero 6-111 y av. Solano, Cuenca, Ecuador
1 shared publication
Latest Publications
- Open Access
- 6 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2424
The Role of Emotions in Health Literacy and Patient Education: Trends, Technologies, and Future Opportunities—A Scoping Review
Background/Objectives: Health literacy and patient education play a key role in supporting informed decision-making, treatment adherence, and disease self-management. While educational interventions have traditionally focused on improving knowledge and understanding, emotions are increasingly recognized as factors associated with learning processes and healthcare experiences. This scoping review mapped the role of emotions in health literacy and patient education by identifying the emotions investigated, assessment methods, technologies employed, educational outcomes, and opportunities for emerging technologies. Methods: A scoping review was conducted following PRISMA-ScR and Joanna Briggs Institute guidance. Searches were finalized in Scopus and PubMed on 6 June 2026, with no publication-date restrictions; only English-language journal articles and reviews were eligible. Two reviewers screened records, extracted data, and classified studies, resolving disagreements by consensus and consulting methodological or clinical co-authors when needed. Results: A total of 135 studies were included. Anxiety and emotional distress were the most frequently investigated emotional categories, whereas emotional support, reassurance, and emotional engagement received less attention. Interviews, surveys, questionnaires, and standardized scales were the predominant assessment methods. Emotional well-being and understanding were the most frequently reported educational outcomes, followed by adherence, communication, and emotional support. Educational programs and educational materials were the most commonly employed approaches, while digital health solutions appeared less frequently. Limited use of artificial intelligence and objective emotion-recognition methods was identified. Conclusions: Emotional factors were associated with several patient-education outcomes, but the heterogeneous and predominantly self-reported evidence does not establish causality. Emerging technologies warrant further evaluation before their effectiveness, feasibility, and safety in patient education can be established.
- 6 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (15) , 2424
Open AccessThe Role of Emotions in Health Literacy and Patient Education: Trends, Technologies, and Future Opportunities—A Scoping Review
Background/Objectives: Health literacy and patient education play a key role in supporting informed decision-making, treatment adherence, and disease self-management. While educational interventions have traditionally focused on improving knowledge and understanding, emotions are increasingly recognized as factors associated with learning processes and healthcare experiences. This scoping review mapped the role of emotions in health literacy and patient education by identifying the emotions investigated, assessment methods, technologies employed, educational outcomes, and opportunities for emerging technologies. Methods: A scoping review was conducted following PRISMA-ScR and Joanna Briggs Institute guidance. Searches were finalized in Scopus and PubMed on 6 June 2026, with no publication-date restrictions; only English-language journal articles and reviews were eligible. Two reviewers screened records, extracted data, and classified studies, resolving disagreements by consensus and consulting methodological or clinical co-authors when needed. Results: A total of 135 studies were included. Anxiety and emotional distress were the most frequently investigated emotional categories, whereas emotional support, reassurance, and emotional engagement received less attention. Interviews, surveys, questionnaires, and standardized scales were the predominant assessment methods. Emotional well-being and understanding were the most frequently reported educational outcomes, followed by adherence, communication, and emotional support. Educational programs and educational materials were the most commonly employed approaches, while digital health solutions appeared less frequently. Limited use of artificial intelligence and objective emotion-recognition methods was identified. Conclusions: Emotional factors were associated with several patient-education outcomes, but the heterogeneous and predominantly self-reported evidence does not establish causality. Emerging technologies warrant further evaluation before their effectiveness, feasibility, and safety in patient education can be established.
- 1 January 2024
- Published by Springer Nature
- p. 31-36
Adult-Onset Still’s Disease (AOSD)
- Open Access
- 26 June 2022
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 6, 100159
Could a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils?
- 26 June 2022
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 6, 100159
Open AccessCould a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils?
- Open Access
- 6 March 2017
- Published by MDPI AG in Antibodies
- Vol. 6 (1) , 4
Neutrophil Extracellular Traps, Antiphospholipid Antibodies and Treatment
Neutrophil extracellular traps (NETs) are a network of extracellular fibers, compounds of chromatin, neutrophil DNA and histones, which are covered with antimicrobial enzymes with granular components. Autophagy and the production of reactive oxygen species (ROS) by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase are essential in the formation of NETs. There is increasing evidence that suggests that autoantibodies against beta-2-glycoprotein-1 (B2GP1) induce NETs and enhance thrombosis. Past research on new mechanisms of thrombosis formation in antiphospholipid syndrome (APS) has elucidated the pharmacokinetics of the most common medication in the treatment of the disease.
- 6 March 2017
- Published by MDPI AG in Antibodies
- Vol. 6 (1) , 4
Open AccessNeutrophil Extracellular Traps, Antiphospholipid Antibodies and Treatment
Neutrophil extracellular traps (NETs) are a network of extracellular fibers, compounds of chromatin, neutrophil DNA and histones, which are covered with antimicrobial enzymes with granular components. Autophagy and the production of reactive oxygen species (ROS) by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase are essential in the formation of NETs. There is increasing evidence that suggests that autoantibodies against beta-2-glycoprotein-1 (B2GP1) induce NETs and enhance thrombosis. Past research on new mechanisms of thrombosis formation in antiphospholipid syndrome (APS) has elucidated the pharmacokinetics of the most common medication in the treatment of the disease.
- Open Access
- 1 March 2015
- Published by Springer Nature in Clinical Rheumatology
- Vol. 34 (S1) , 45-49
Education for patients with rheumatoid arthritis in Latin America and the Caribbean
Patient education is highly recommended in rheumatoid arthritis (RA) to support patient management. The challenge is to adhere to the recommendations for providing health education to RA patients in Latin American and the Caribbean (LAC) countries taking into account factors such as patient health illiteracy, lack of rheumatologists, and lack of resources including access to disease-modifying antirheumatic drugs (DMARDs). As existing educational material in regional languages is not readily available and inadequate, we propose developing a web-based educational program that would fulfill the requirements of most patients with RA across LAC countries with an emphasis on the correct and safe use of methotrexate.
- 1 March 2015
- Published by Springer Nature in Clinical Rheumatology
- Vol. 34 (S1) , 45-49
Open AccessEducation for patients with rheumatoid arthritis in Latin America and the Caribbean
Patient education is highly recommended in rheumatoid arthritis (RA) to support patient management. The challenge is to adhere to the recommendations for providing health education to RA patients in Latin American and the Caribbean (LAC) countries taking into account factors such as patient health illiteracy, lack of rheumatologists, and lack of resources including access to disease-modifying antirheumatic drugs (DMARDs). As existing educational material in regional languages is not readily available and inadequate, we propose developing a web-based educational program that would fulfill the requirements of most patients with RA across LAC countries with an emphasis on the correct and safe use of methotrexate.
- 1 February 2014
- Published by Elsevier in Journal of Autoimmunity
- Vol. 48-49, 26-30
Diagnosis and classification of rheumatoid arthritis
- 1 February 2014
- Published by Elsevier in Journal of Autoimmunity
- Vol. 48-49, 26-30
Diagnosis and classification of rheumatoid arthritis
- 1 February 2012
- Published by Elsevier in Autoimmunity Reviews
- Vol. 11 (4) , 288-295
Obstetric antiphospholipid syndrome
- 1 February 2012
- Published by Elsevier in Autoimmunity Reviews
- Vol. 11 (4) , 288-295
Obstetric antiphospholipid syndrome
- 1 December 2010
- Published by Elsevier in Autoimmunity Reviews
- Vol. 10 (2) , 108-111
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus
- 1 December 2010
- Published by Elsevier in Autoimmunity Reviews
- Vol. 10 (2) , 108-111
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus